Frequency of red blood cell alloantibody in Kuwaiti population

Medical Principles and Practice

Volumn 14, Issue 4, 2005, Pages 230-234

  Ameen, Reem ^a,c   Al Eyaadi, Ohood ^b   Al Shemmari, Salem ^a   Chowdhury, Rafiqul ^a   Al Bashir, Abdulaziz ^b  

^a KUWAIT UNIVERSITY   (Kuwait)

^b MINISTRY OF HEALTH   (Kuwait)

^c NONE   (Kuwait)

Author keywords

Alloimmunization, frequency; Arabs; Kuwait; Red blood cells

Indexed keywords

ALLOANTIBODY; RHESUS D ANTIBODY; RHESUS E ANTIBODY;

ADULT; ALLOIMMUNIZATION; ANTIBODY DETECTION; ANTIBODY SPECIFICITY; ARTICLE; BLOOD DONOR; BLOOD GROUP LEWIS SYSTEM; DEMOGRAPHY; ERYTHROCYTE; FEMALE; HUMAN; MALE; POPULATION RESEARCH; PREGNANT WOMAN; SCREENING TEST; SEROPREVALENCE; SEX DIFFERENCE;

BLOOD DONORS; BLOOD GROUP ANTIGENS; CONSANGUINITY; FEMALE; HUMANS; ISOANTIBODIES; KUWAIT; MALE; PREGNANCY; PREVALENCE; RETROSPECTIVE STUDIES; SEROEPIDEMIOLOGIC STUDIES; SEROLOGIC TESTS; SEX DISTRIBUTION;

EID: 20844432096     PISSN: 10117571     EISSN: None     Source Type: Journal    
DOI: 10.1159/000085740     Document Type: Article

References (16)

1. Fluit CR, Kunst VA, Drenthe-Schonk AM: Incidence of red cell antibodies after multiple blood transfusion. Transfusion 1990;30:532-535.
2. Redman M, Regan F, Contreras M: A prospective study of the incidence of red cell alloimmunization following transfusion. Vox Sang 1996;71:216-220.
3. Walker RH, Lin DT, Hartrick MB: Alloimmunization following blood transfusion. Arch Pathol Lab Med 1989;113:254-261.
4. Winters JL, Pinedo AA, Gorden LD, et al: RBC alloantibody specificity and antigen potency in Olmsted County, Minnesota. Transfusion 2001;41:1413-1420.
5. Public Authority for Civil Information (PACI): Directory of Civil Information: Regulation and Labor Force 2001, Kuwait.
6. Shall NM, Shah MA: Socioeconomic and health care determinants of child survival in Kuwait. J Biosoc Sci 1990;22:239-253.
7. Radovanovic A, Shah N, Behbehani J: Prevalence and social correlates of consanguinity in Kuwait. Ann Saudi Med 1999;19:206-210.
8. Vengelen Tyler V, et al: Technical Manual, ed 12. American Association of Blood Bank, 1996.
9. Hoeltge GA, Domen RE, Rybicki LA, Schaffer PA: Multiple red cell transfusion and alloimmunization: Experience with 6,996 antibodies detected in a total of 159,262 patients from 1985 to 1993. Arch Pathol Lab Med 1995;119:42-45.
10. Spielmann W, Seidl S: Prevalence of irregular red cell antibodies and their significance in blood transfusion and antenatal care. Vox Sang1974;26:551-559.
11. Moreira G, Bordin J, Kuroda A, Kerbauy J: Red blood cell alloimmunization in sickle cell disease: The influence of racial and antigenic pattern differences between donors and recipients in Brazil. Am J Hematol 1996;52:197-200.
12. Giblett ER: Blood group alloantibodies: An assessment of some laboratory practices. Transfusion 1977;71:266-274.
13. 0 (D)? Vox Sang 1984;47:205-208.
14. Health and Vital Statistics Division: Vital Health and Statistics Abstract. Kuwait Health. Kuwait, Department of Medical Records and Statistics Ministry of Health, 1999, p 43.
15. Lee D, Contreras M, Robson S, Rodeck C, Whittle M: Recommendations for the use of anti-D immunoglobulin for Rh prophylaxis. Transfus Med 1999;9:93-97.
16. Brantley SG, Ramsey G: Red cell alloimmunization in multi-transfused HLA typed patients. Transfusion 1988;28:463-466.